Newcastle University announces ground-breaking melanoma biomarker
Scientists have developed a new prognostic test to improve doctors’ ability to identify which early-stage patients are at a greater risk of their melanoma spreading. The research, part-funded by Melanoma Focus, uses 2 protein biomarkers to help them assess which patients are at high or low risk of disease progression beyond stage 1.
READ MORETalking About Melanoma Matters – Discussion Guide
Published by Bristol-Myers Squibb in conjunction with the UK’s leading melanoma charities, this guide aims to improve the conversations between patients and their healthcare professionals at diagnosis, treatment and living beyond melanoma. It is based on a survey of more than 100 patients.
READ MOREResearch into birthmarks and melanoma
Newcastle University’s Institute of Genetic Medicine is to study the link between rare types of birthmark and a predisposition to melanoma. The project, supported by a grant from Melanoma Focus, aims to discover what is different at the genetic level in such birthmarks.
READ MORE
Virgin Money London Marathon 2020
If you want to join the long list of supporters who have already taken on this famous marathon to support our work, then please let us know.
READ MORE